Described herein are compounds and pharmaceutical compositions containing such compounds that antagonize the PGD2 activated chemoattractant receptor-homologous molecule expressed on TH2 cells (CRTH2). Also described herein are methods of using such CRTH2 antagonists, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other PGD2-dependent or PGD2 mediated conditions or diseases.
本文描述了一些化合物和含有这些化合物的药物组合物,这些化合物可以拮抗
PGD2激活的趋化剂受体同源分子在TH2细胞上的表达(CRTH2)。本文还描述了使用这种CRTH2拮抗剂的方法,单独或与其他化合物联合使用,用于治疗呼吸系统、心血管系统和其他依赖于
PGD2或通过
PGD2介导的疾病或疾病。